Source link : https://newshealth.biz/health-news/perioperative-durvalumab-plus-flot-boosts-efs-in-resectable-gastric-gej-cancer/
(MedPage Today) — CHICAGO — Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) compared with FLOT alone in patients with resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma… Source link : https://www.medpagetoday.com/meetingcoverage/asco/115836 Author : Publish date : 2025-06-01 12:00:00 Copyright for syndicated content belongs to the linked Source.
The post Perioperative Durvalumab Plus FLOT Boosts EFS in Resectable Gastric/GEJ Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-01 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8